C12N 2710/16221
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2710/16221 (Viruses as such) appears on 1 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 8
- Assignees
- 5
- Inventors
- 19
- Latest grant
- 14 Sep 2010
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
By publication year.
Recent patents
- Method for manufacturing hek293 cell line, method for manufacturing eb-vlps and composition comprising said eb-vlps30 Nov 2023US 2023/0381300 A1Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
- Targets and methods for treating epstein-barr virus mediated neurodegeneration12 May 2022US 2022/0145302 A1Battle Biotech L.L.C.
- Compositions and methods for engineering cells14 Jan 2016US 2016/0010113 A1Life Technologies Corporation
- Compositions and Methods for Engineering Cells14 Feb 2013US 2013/0040304 A1Life Technologies Corporation
- Compositions and Methods for Engineering Cells27 Oct 2011US 2011/0263001 A1Life Technologies Corporation
Most cited
By later US patents